2 Firms To Lead Investor Suit Over Myovant-Sumitomo Deal
Two firms have been named lead counsel for a proposed class action against Myovant Sciences Ltd. and Sumitomo Pharma America Inc. claiming lawyers from Skadden Arps Slate Meagher & Flom LLP...To view the full article, register now.
Already a subscriber? Click here to view full article